Vanda Pharmaceuticals
VNDA
VNDA
157 hedge funds and large institutions have $222M invested in Vanda Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 53 increasing their positions, 56 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
-22
Holders Change %
-12.29%
% of All Funds
2.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
53
Reduced
56
Closed
47
Calls
$211K
Puts
$88K
Net Calls
+$123K
Net Calls Change
+$171K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$17.1M |
2 |
2
BlackRock
New York
|
$35.2M |
3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$9.55M |
4 |
![]()
4
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$6.03M |
5 |
5
Renaissance Technologies
New York
|
$15.5M |